We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.AMENDED AND RESTATED ASSET PURCHASE AGREEMENT among: RAPTOR PHARMACEUTICALS INC., a Delaware corporation; RAPTOR PHARMACEUTICAL CORP., a Delaware corporation; and TRIPEX PHARMACEUTICALS, LLC, a Delaware limited liability company Dated as of October 2,...Asset Purchase Agreement • October 5th, 2015 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 5th, 2015 Company Industry JurisdictionTHIS AMENDED AND RESTATED ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 2, 2015, by and among: RAPTOR PHARMACEUTICALS INC., a Delaware corporation (the “Purchaser”); RAPTOR PHARMACEUTICAL CORP., a Delaware corporation (“Parent”); and TRIPEX PHARMACEUTICALS, LLC, a Delaware limited liability company (the “Seller”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
ASSET PURCHASE AGREEMENT between: RAPTOR PHARMACEUTICAL CORP., a Delaware corporation; and TRIPEX PHARMACEUTICALS, LLC, a Delaware limited liability company Dated as of August 20, 2015Asset Purchase Agreement • September 8th, 2015 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 8th, 2015 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of August 20, 2015, by and between: RAPTOR PHARMACEUTICAL CORP., a Delaware corporation (the “Purchaser”); and TRIPEX PHARMACEUTICALS, LLC, a Delaware limited liability company (the “Seller”). Certain capitalized terms used in this Agreement are defined in Exhibit A.